- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Challenges in the Management of Oral Oncolytics
During this segment, Bruce Feinberg; DO; Scott Gottlieb, MD; Brian Kiss, MD; and Michael Kolodziej, MD, highlight the issues that payers are encountering with the increased utilization of oral oncolytics and discuss how these issues are being addressed.
Dr Feinberg remarks that oral oncolytics are associated with high costs, which affects adherence, medication therapy management, and overall cost.
Payers are trying to manage these issues by splitting out “specialty pharmacy” medications and working with vendors to negotiate better prices, comments Dr Kiss. However, payment systems are becoming more complex and it is challenging to ensure that oncologists know to which types of pharmacies they should refer their patients for savings.
Professionals are recognizing an increased amount of drug wastage in the handling of these therapies, adds Dr Kiss. For example, many oral oncolytic prescriptions can be ordered via mail. Patients receive a large supply of their oral oncolytic; however, they may need to stop taking the medication due to tolerance issues.
Dr Kolodziej and Dr Gottlieb discuss the systems that pharmacy benefit managers have established in an attempt to resolve these issues.
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
